$RFL News Article - Rafael Pharmaceuticals Achieves Target Enrollment of 500 Patients in Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 ? (devimistat) for Patients with Metastatic Pancreatic Cancer
https://marketwirenews.com/news-releases/rafa...24772.html